We are live on
!
Find out more
CI
Clal Insurance Portfolio holdings
AUM
$16.6B
1-Year Est. Return
68.34%
This Fund
S&P 500
This Quarter
Est. Return
+0.22%
1 Year Est. Return
+68.34%
3 Year Est. Return
+151.82%
5 Year Est. Return
+175.48%
10 Year Est. Return
+729.64%
AUM
$3.93B
AUM Growth
+$505M
(+15%)
Cap. Flow
+$516M
Cap. Flow
% of AUM
13.12%
Top 10 Holdings %
Top 10 Hldgs %
47%
Holding
107
New
10
Increased
20
Reduced
24
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
|
+$299M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$198M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$90.3M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$43.2M |
| 5 |
PayPal
PYPL
|
+$26.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$68.5M |
| 2 |
Perrigo
PRGO
|
+$55.9M |
| 3 |
Cisco
CSCO
|
+$33.3M |
| 4 |
GE Aerospace
GE
|
+$31.9M |
| 5 |
Steel Dynamics
STLD
|
+$26.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.25% |
| 2 | Financials | 4.97% |
| 3 | Technology | 3.04% |
| 4 | Utilities | 2.52% |
| 5 | Industrials | 1.56% |
Similar funds
AIMCA
EIP
IG
BCIM
UCFA
VMPIC
LCOV
Clal Insurance's Q2 2016 Portfolio in Review
As of Q2 2016, Clal Insurance held 107 positions worth $3.93B, up 15% from $3.43B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Clal Insurance deployed $516M of net new capital in Q2 2016, opening 10 new positions and adding to 20 existing holdings. Its largest new stake was Xtrackers MSCI Japan Hedged Equity ETF: 9,132,763 shares worth $281M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 17% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $68.5M trimmed.
- Clal Insurance's largest Q2 2016 buy was Xtrackers MSCI Japan Hedged Equity ETF: 9,132,763 shares worth $281M.
- Clal Insurance added most to iShares MSCI Emerging Markets ETF in Q2 2016, an estimated $198M increase.
- Clal Insurance's biggest Q2 2016 reduction was Teva Pharmaceuticals, cutting an estimated $68.5M.
- Clal Insurance fully exited Check Point Software Technologies in Q2 2016, selling an estimated $16.8M.
- Clal Insurance's ten largest holdings make up 47% of its $3.93B portfolio in Q2 2016.
- Clal Insurance opened 10 new positions and closed 4 in Q2 2016.
- Clal Insurance's portfolio value rose 15% quarter-over-quarter to $3.93B.
Based on Clal Insurance's 13F filing for Q2 2016, filed 8 Aug 2016.